86 related articles for article (PubMed ID: 3698033)
1. Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas.
Bauer KD; Merkel DE; Winter JN; Marder RJ; Hauck WW; Wallemark CB; Williams TJ; Variakojis D
Cancer Res; 1986 Jun; 46(6):3173-8. PubMed ID: 3698033
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas.
Bauer KD; Lincoln ST; Vera-Roman JM; Wallemark CB; Chmiel JS; Madurski ML; Murad T; Scarpelli DG
Lab Invest; 1987 Sep; 57(3):329-35. PubMed ID: 3626522
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
Harlow SP; Eriksen BL; Poggensee L; Chmiel JS; Scarpelli DG; Murad T; Bauer KD
Cancer Res; 1991 May; 51(9):2403-9. PubMed ID: 2015602
[TBL] [Abstract][Full Text] [Related]
4. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid flow cytometry in large cell lymphoma.
McLaughlin P; Osborne BM; Johnston D; Jennings P; Butler JJ; Cabanillas F; Barlogie B
Cancer Res; 1988 Nov; 48(22):6614-9. PubMed ID: 3180071
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ
Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
13. DNA content of T-cell lymphomas. A flow-cytometric analysis.
Egerter DA; Said JW; Epling S; Lee S
Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
[TBL] [Abstract][Full Text] [Related]
14. DNA content and proliferative activity in children with neuroblastoma.
Yalçin B; Kutluk T; Kansu E; Göğüş S; Canpinar H; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2000; 17(1):45-54. PubMed ID: 10689714
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma.
Schutte B; Reynders MM; Wiggers T; Arends JW; Volovics L; Bosman FT; Blijham GH
Cancer Res; 1987 Oct; 47(20):5494-6. PubMed ID: 3652050
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma.
Isobe H; Sridhar KS; Doria R; Cohen F; Raub WA; Saldana M; Krishan A
Cytometry; 1995 Jan; 19(1):86-91. PubMed ID: 7705189
[TBL] [Abstract][Full Text] [Related]
19. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
[TBL] [Abstract][Full Text] [Related]
20. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]